trial

Ketogenic Diet in People With Schizophrenia

NCTId NCT05968638
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 50 (estimated)
Sponsored by University of Maryland, Baltimore County
Primary completion 2026-08-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
50 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2023-09-01
Primary completion
2026-08-01
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Regular DietKetogenic Diet

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Investigators

1
Deanna L. Kelly, Pharm.D., BCPPPrincipal Investigator

Sites

1 total
Catonsville, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2026-08-01
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Regular Diet
drug
Ketogenic Diet
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Schizophrenia
indication
investigator
Deanna L. Kelly, Pharm.D., BCPP
person